Chronic Leukemia

Chronic Leukemia News

  • FDA Approves More Convenient Form of Roche Blood Cancer Drug U.S. health regulators on Thursday approved a new formulation of Roche's big-selling cancer drug Rituxan (rituximab) for three common types of blood cancers that allows for relatively quick administration via injection under the skin in place of a lengthy intravenous infusion, the company said.
  • Alert Three More Biosimilar Rituximab Products in Europe More biosimilar rituximab products are coming to Europe, bringing hope of lower prices.

Chronic Leukemia Perspective